Physician profile
Garold E Motes
NPI 1114212206
$4,415.05
in general payments reported to CMS, 2019-2025
34 companies · $783 in 2025
The $783 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.01 · 2020: $73.55 · 2021: $1,442 · 2022: $769 · 2023: $526 · 2024: $756 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $947.87 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $844.39 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Surmodics, INC. | $434.42 | 2023-2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Baxter Healthcare | $308.38 | 2022-2024 | Preveleak, Ostene |
| Medtronic, INC. | $219.68 | 2021-2024 | Intellis Adaptivestim |
| Silk Road Medical, INC. | $191.26 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $153.08 | 2020-2022 | |
| Bone Support INC. | $152.51 | 2024 | Cerament G, Ceramentbone Void Filler |
| Angiodynamics, INC. | $140.90 | 2021-2022 | |
| Medinc of Texas | $119.33 | 2024 | |
| Corcym INC | $92.08 | 2022 | |
| Ethicon US, LLC | $85.76 | 2021-2024 | Evarrest, Stratafix |
| Tactile Systems Technology INC | $75.30 | 2020-2022 | |
| Stryker Corporation | $74.03 | 2025 | Inthrill Thrombectomy Catheter, Clottriever Bold Catheter |
| Davol INC. | $49.37 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $46.73 | 2021 | |
| Kci USA, INC. | $46.03 | 2021 | |
| Triad Life Sciences INC. | $44.64 | 2021 | |
| Boston Scientific Corporation | $42.84 | 2022-2024 | |
| Bard Peripheral Vascular, INC. | $36.41 | 2019-2023 | Venovo |
| Shockwave Medical, INC | $33.51 | 2025 | |
| Aroa Biosurgery Incorporated | $28.25 | 2023 | |
| Kerecis Limited | $28.09 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Endologix LLC | $25.73 | 2022 | |
| Dilon Technologies, INC. | $25.00 | 2023 | Hemoblast Bellows |
| Philips North America LLC | $24.53 | 2019 | |
| Smith+Nephew, INC. | $23.77 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.84 | 2021 | |
| Lemaitre Vascular, INC. | $19.72 | 2023 | Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $19.05 | 2019 | |
| Baylis Medical Technologies INC. | $18.12 | 2024 | |
| Argon Medical Devices, INC. | $18.04 | 2025 | Clot Management |
| Integra Lifesciences Corporation | $13.83 | 2023 | Advanced Wound Care |
| Convatec INC. | $12.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garold Motes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.